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Intracellular calcium handling by fibroblasts from non-insulin depen-
dent diabetic patients with and without hypertension and microalbumin-
uria. Intracellular calcium ([(Ca2)1]) plays a role in many cellular
functions, and is involved in the pathogenesis of some conditions observed
in non-insulin dependent diabetic patients (NIDDM), such as hyperten-
sion and insulin resistance. Hyperinsulinemia and hyperglycemia are also
implicated in the pathogenesis of chronic diabetes complications. It is not
clear whether disturbances in [(Ca2)j are accounted for only by meta-
bolic abnormalities of diabetes or by other mechanisms. The aim of this
study was to investigate [(Ca2)j handling by skin fibroblasts in NIDDM
patients with similar features regarding diabetes duration and metabolic
control, but who differ concerning blood pressure levels and albumin
excretion rate. Using a fluorimetric technique with the indicator Fura-2/
AM, we investigated the effect of chronic exposure to insulin and glucose
on [(Ca2)1 after FGF stimulation in fibroblasts from NIDDM with
hypertension alone (NIDDM H+M—) and with hypertension and mi-
croalbuminuria (NIDDM H+M+) in comparison with normotensive
normoalbuminuric NIDDM (NIDDM H—M—) and control subjects (C).
We studied also a group of hypertensive non-diabetic subjects (HYPER).
We found that (1) FGF ipcreases [(Ca2)] in all subjects; (2) insulin or
high glucose per se increase [(Ca2)] in NIDDM H+M+ and NIDDM
H+M— with respect to NIDDM H—M— and C; (3) HYPER show a
[(Ca2)1] response similar to that of NIDDM H+M— and NIDDM
H+M+; (4) when stimuli are combined, all NIDDM have altered
[(Ca2)j with respect to C, but NIDDM H+M—, NIDDM H+M+ and
HYPER have higher values than NIDDM H—M—. This disorder in
[(Ca2)1] appears to be an intrinsic feature of a subgroup of hypertensive
NIDDM patients, which persists in cultured cells, at least partially
independent of the metabolic challenge of diabetes in vivo, and could
contribute to the development of their renal and cardiovascular compli-
cations.
Increased intracellular calcium concentration is frequently
found in insulin dependent (IDDM) and non-insulin dependent
diabetes (NIDDM), obesity and essential hypertension [1]. Not
only intracellular calcium ([(Ca2)1]), but also its hormonal
regulation may be abnormal in NIDDM [2]. Whether distur-
bances in [(Ca2)1] in diabetes are primary genetic defects or
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acquired metabolic abnormalities is not fully understood. The
impaired function of pancreatic B cell leads to hyperglycemia,
which in turn determines changes in [(Ca2)1] [31. Alternatively, it
has been suggested that a primary abnormality in [(Ca2)] may be
the basic defect initiating parallel impairments in insulin action
and secretion [1].
Renal complications develop uniformely only in 20 to 40% of
IDDM patients [4, 5]. Abnormalities in kidney function are also
associated with familial predisposition to diabetic nephropathy in
IDDM [61, in NIDDM Pima Indians [71, as well to predisposition
to cardiac ischemic disease [8] and to essential hypertension [9] in
IDDM. Our group has demonstrated that microalbuminuria is
linked to clinical features of renal and cardiac hypertrophy in a
cohort of IDDM [10], NIDDM [11] and hypertensive [12] pa-
tients. Furthermore, diabetic and hypertensive patients with ab-
normalities in renal and cardiac size also show altered sodium-
lithium countertransport activity in red blood cells [10] and
sodium-hydrogen exchange in cultured skin fibroblasts [13]. It is
emphasized that cultured skin fibroblasts from IDDM patients
with diabetic nephropathy, but not those without, show enhanced
growth rate [13]. The nature of the pathogenetic link between
abnormalities in sodium-hydrogen exchange and cell growth has
not been elucidated. The regulation of cytoplasmatic pH by
sodium-hydrogen antiport is of crucial importance in the mito-
genic response [14]. The activity of sodium-hydrogen antiport is
tightly correlated with the [(Ca2)] [15]. Himpens, de Smedt and
Casteels [16] and others [171 have suggested that a specific
regulation of [(Ca2)1] determines gene expression or cellular
proliferation. Derangement in [(Ca2)1] homeostasis may be of
significance in the pathogenesis of renal and cardiac hypertrophy
in diabetes and essential hypertension [1]. A great variety of
cellular signals induced by secreted polypeptides modulates
growth and differentiation of individual cell types in higher
organisms. One large group of growth factors acts by binding to
cell surface receptors with intrinsic protein tyrosine kinase activ-
ity. Insulin and FGF play a fundamental role in mitogenesis,
promoting cell tyrosine kinase activity [18]. Signaling pathways
initiated by tyrosine phosphorilation lead to changes in [(Ca2)1],
which in turn elicits different biological responses in cell growth
and proliferation [11. It can be postulated that disturbances in
[(Ca2)1] handling are one of the pathogenetic mechanisms
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Table 1. Clinical features of seven normal subjects (Controls), five hypertensive non-diabetic patients (HYPER), seven normotensive
normoalbuminuric NIDDM patients (NIDDM H—M—), seven hypertensive normoalbuminuric NIDDM patients (NIDDM H+M—) and nine
hypertensive microalbuminuric NIDDM patients (NIDDM H+M+)
Controls HYPER NIDDM H-M- NIDDM H+M- NIDDM H+M+
Number (male/female) 7 (4/3) 5 (2/3) 7 (5/2) 7 (4/3) 9 (5/4)
Ageyears 55±3 52±3 55±3 56±4 56±2
BMIkg/m2 29±3 31±3 27±3 26±3 30±3
Disease duration years — — 7.2 1.0 7.3 0.8 8.2 2.0
HbAlc % 5.1 0.2 4.5 0.7 7.8 1.2 7.6 1.Oa 7.9 1.9
SBP mm Hg
DBP mm Hg
126 5
78 2 165 5°'94 5ah
130 7
76 4
168 8'
92 4ab
17097 s'
AER 1g/min
Serum creatinine p.mol/liter
6 (2—9)78 4 8 (2—11)80 4 7 (1—9)73 6 11(3—16)70 5 77 (31_169)a97 5'
GFRmI/min/1.73m2 101±4 112±3 103±4 110±4 115±2a
Data are expressed as mean SE (AER is expressed as mean with range).
ap < 0.05 vs. Controls; bp < 0.05 vs. NIDDM H—M—
accounting for derangements in cell growth in NIDDM. Further-
more, defects in hormonal modulation of [(Ca2)1] could more
particularly characterize the cohort of diabetic patients with tissue
complications.
The aim of the present study was to investigate the effect of
FGF challenge, after chronic exposure to different glucose and
insulin concentrations, on [(Ca2)] homeostasis in cultured skin
fibroblasts from NIDDM patients with microalbuminuria and
hypertension, who are characterized by renal and cardiac hyper-
trophy [11], in comparison with hypertensive NIDDM patients
and NIDDM patients without abnormalities in kidney function
and blood pressure levels. A group of hypertensive, non-diabetic
subjects was also studied as control group to further clarify the
role of hypertension in determining [(Ca2)1] disturbances in
cultured fibroblasts.
Methods
We have studied seven normotensive normoalbuminuric
NIDDM patients (NIDDM H—M—), seven hypertensive nor-
moalbuminuric NIDDM patients (NIDDM H+M—) and nine
hypertensive microalbuminuric NIDDM patients (NIDDM
H + M +), comparing them to five hypertensive, non-diabetic
subjects (HYPER) and seven control subjects (C). All patients
were attending the outpatients' diabetes clinic of the Internal
Medicine Department of the University of Padova, and they were
in satisfactory metabolic control at the time of the investigation.
Duration of disease and glycated hemoglobin (HbAlc) values
were superimposable in all diabetic patients (Table 1). Controls
and hypertensive, non-diabetic subjects were matched closely for
age, gender, body mass index (BMI) and serum creatinine with
the patients (Table 1), and none had family history or clinical
evidence of diabetes or hypertension.
Three NIDDM H-M-, four NIDDM H+M—, and six
NIDDM H+M+ followed an isocaloric diet with 55% carbohy-
drate, 30% lipid and 15% protein content, and took glibenclamide
tablets. Two NIDDM H—M—, three NIDDM H+M— and three
NIDDM H+M+ patients were only on insulin therapy. No
variation was observed with regard to individual daily insulin or
glibenclamide requirement during the 12 month period preceding
skin biopsy. All NIDDM H+M+, NIDDM H+M- and HYPER
patients had a new diagnosis of arterial hypertension, and they
started pharmacological therapy after the skin biopsy.
All subjects were of European origin and gave informed
consent to the study, which was approved by the Ethical Commit-
tee of the University of Padova.
On the morning of the skin biopsy, height and weight were
recorded, and blood was taken for determination of plasma
glucose, serum creatinine and HbAlc. Arterial blood pressure was
measured with a standard mercury sphygmomanometer, to the
nearest 2 mm Hg, in the dominant arm after more than 10
minutes of rest in a supine position. Three timed, 24-hour urine
samples were collected for measurement of urinary albumin
excretion rate (AER) by radioimmunoassay [19], and the median
value was used for calculation. Glomerular filtration rate (GFR)
was evaluated by plasma clearance of 51Cr EDTA [20] within the
month following the skin biopsy.
Systolic and diastolic blood pressure levels were significantly
higher in NIDDM H+M+, in NIDDM H+M— and in HYPER
than in NIDDM H—M— and C by definition of recruitment
criteria (Table 1). GFR was slightly higher in NIDDM H+M+, in
NIDDM H+M- and in HYPER than in NIDDM H-M- and C
(Table 1).
Cell culture
A skin biopsy was taken from forearm anterior surface by
excision under local anaesthesia (ethyl chloride). Fibroblasts were
half-divided and cultured in Dulbecco's minimum essential me-
dium (DMEM) supplemented with 10% FCS at two different
D-glucose concentrations (5.5 m and 22 mM) at 37°C. Mannitol
was systematically added to 5.5 m medium to bring total
osmolality to values equivalent to 22 mivi glucose. After the fourth
passage, cells were harvested and stored in liquid nitrogen. For
each experiment, fibroblasts were thawed and grown as described
above, maintaining the same experimental conditions during all
culture passages. All experiments were performed between the
6th and the 10th passages.
Measurement of [(Ca2)j
[(Ca2)1] was measured using the Fura-2 technique as described
previously [21]. Forty-eight hours before the experiment, cells
were isolated by a two-minute enzymatic digestion with 0.025%
trypsin and 0.02% EDTA in phosphate-buffered saline (PBS),
placed in a monolayer on a coverslip glass in a final number of
150,000 and supplemented for 24 hours with DMEM. Thirty-six
hours before the experiments, the culture medium was removed,
and the cells were equilibrated in serum-free DMEM at the same
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D-glucose concentration (5.5 or 22 mM) and in absence or
presence of insulin (4 ig/ml for 36 hr). We have opted for this
36-hours period for two main reasons: (a) this is a long enough
quiescent phase to have an interruption of the replicative activity
and DNA synthesis of fibroblasts, and would avoid a variation of
pH and other intracellular parameters that could affect the
results; and (b) chronic hyperinsulinemia is the usual metabolic
feature of NIDDM patients, and therefore, a 36-hour in vitro
exposure to insulin was thought to mimic to some extent the
hormonal milieu of NIDDM in vivo.
On the morning of the experiment, fibroblasts were incubated
in serum-free DMEM containing Fura-2/AM 2 p. (Boehringer
Manheim Biochimica, Germany) and D-glucose concentrations as
indicated (D-glucose did not interfere with Fura-2/AM loading or
with cleaving of the Fura-2 ester). After an incubation of 30
minutes at 37°C, cells were rinsed twice with a HEPES-buffered
solution (pH 7.4) and equilibrated for 15 minutes at 25°C in the
same solution.
For the determination of Ca2 release, HEPES-buffered solu-
tion with the addition of CaCl2 was used.
[(Ca2)1] was monitored with thermostatically controlled
(37°C) dual-wavelength spectrofluorimeter, equipped with a
quartz cuvette holder. Fluorescence measurements were made
using double excitatory wavelength measurements (340 to 380
nm) and a single emission wavelength (500 nm). Slits were set at
10 nm for both excitation and emission. According to the equation
of Grynkiewicz, Pienie and Tsien [22], [(Ca2)I = Kd X 5f2/Sb2
x (R — R,i,)/(Rmax — R) (nM), where R is the fluorescence ratio,
Rm is the maximum R, Rmn is the minimal R, and Sf2/Sb2 is the
ratio of the fluorescence intensity of the free and bound dye at 380
nm excitation. An R,ax of 340/380 nm was measured after
saturation of intracellular Fura-2 with Ca2 by adding 2 LM
ionomycin (Calbiochem, La Jolla, CA), to allow equilibration with
extracellular Ca2t We evaluated [(Ca2)] in the resting condi-
tion and after acute injection of FGF 20 n (Sigma Chemical
Company, St. Louis, MO, USA), performed by a Hamilton syringe
in about one second. Some experiments were then repeated in
absence of external Ca2t
To exclude the possible role of hyperosmolality in determining
values obtained at 22 m glucose concentration, we repeated
those experiments using an isoosmoting solution in which glucose
was replaced by mannitol.
Mn2 quench experiments
Mn2 utilizes the same pathway as Ca2 to enter cells, quench-
ing the Fura-2 signal because of its higher affinity for the probe
[23]. For Mn2 entry experiments, fibroblasts were loaded with
Fura-2/AM as described above, equilibrated for 15 minutes in the
presence of MnC12 (instead of CaC12) and stimulated with FGF 20
nM. To determine Mn2 influx, the excitation wavelength of 360
nm, the isosbestic point of Fura-2, was used, with 500 nm
emission. Therefore, the amount of Mn2-induced quench re-
flects the net Mn2 influx, while the slope of the fluorescence
quenching indicates the permeability of the Ca2 entry pathway.
Analysis of data
Means SE were calculated for the variables selected for
statistical analysis. We have applied a two-way analysis of variance
Table 2. (Ca2) (nmol/liter) in the baseline State at 5.5 and 22 mM
glucose concentrations, with and without chronic insulin stimulation in
cultured skin fibroblasts from Controls, hypertensive non-diabetic
subjects (HYPER), normotensive normoalbuminuric NIDDM patients
(NIDDM H—M--), hypertensive normoalbuminuric NIDDM patients
(NIDDM H+M—) and hypertensive microalbuminuric NIDDM
patients (NIDDM H+M+)
Without chronic
insulin stimulation
5.5 mM 22 ms
glucose glucose
With chronic
insulin stimulation
5.5 mi 22 mM
glucose glucose
Controls
HYPER
NIDDM H—M—-
NIDDM H+M—
NIDDM H+M+
63.2 2.2 64.3 2.3
71.7 3.1 77.8 3.8
60.0 7.2 85.2 7.4
70.5 3.3 79.6 3.8
73.9 4.0 69.6 5.3
91.7 7.2 89.6 4.6°
85.2 9.3 89.9 4.4
78.0 4.7 83.8 7.0
91.9 3.7 95.1 5.6
96.3 57° 99.6 4.6a
Data are expressed as mean SE.
P < 0.05 vs. without insulin
for repeated measures and Bonferroni test for multiple compar-
isons. A P value < 0.05 was considered statistically significant.
Results
[(Ca2),J in the basal state
Skin fibroblasts cultured at 22 m glucose concentration had
similar [(Ca2)1] to that observed at 5.5 m glucose and at
mannitol induced hyperosmolar conditions (data not shown).
Chronic insulin stimulation resulted in a significant increase of
baseline [(Ca2)1] in C, in NIDDM H+M— and in NIDDM
H+M+ (P < 0.05; Table 2).
(ICa2I1) after FGF challenge
FGF determined an abrupt surge of [(Ca2)1] in all groups. This
effect was observed in fibroblasts at 5.5 and 22 mM glucose
concentration and in presence or absence of chronic exposure to
insulin. Data concerning C, NIDDM H—M— and NIDDM
H+M+ are represented in Figures 1, 2 and 3.
NIDDM H+M+, NIDDM H+M- and HYPER patients, in
absence of insulin, had significantly enhanced [(Ca2)1] response
to high glucose levels than NIDDM H—M— and C, both when
data were expressed as absolute values (Table 3) and peak
increase values above baseline patterns (data not shown). No
difference was observed between NIDDM H—M— and C (Table 3).
Chronic insulin stimulation determined a significant increase in
[(Ca2)1] in all groups at 5.5 m glucose concentration, without
difference between C and NIDDM H—M— (Table 3). Moreover,
it magnified the effects of high glucose on [(Ca2)1J of fibroblasts
response to FGF challenge (Table 3). The combined effect of
insulin and high glucose stimulation was significantly higher in all
patient groups than in C (Table 3). During a combined chronic
stimulation with insulin and high glucose, NIDDM H + M +,
NTDDM H+M— and HYPER patients exhibited an enhanced
[(Ca2)1] surge after FGF challenge respect to NIDDM H—M—
patients (P < 0.05; Table 3).
To test the possible independent effect of our different exper-
imental conditions, in each single subject we have calculated the
delta for glucose (z G), insulin (z I) and glucose + insulin ( GI),
Solini et a!: Intracellular calcium in NIDDM 621
repeating the statistical analysis on these parameters. The results
are in Table 4.
In NIDDM H+M+, NIDDM H—M— and C, some experi-
ments were also repeated in absence of CaCI2 addition in the
external buffer. Also in these experimental conditions NIDDM
H+M+ and NIDDM H—M— patients showed a higher surge of
[(Ca2)} with respect to C in response to FGF during chronic
exposure to high glucose and insulin concentrations (Fig. 4).
Again, NIDDM H+M+ showed an increased [(Ca2)1] response
to these hormonal and metabolic stimuli than NIDDM H—M—
(P < 0.05).
In order to speculate if any relationship could be observed
between some clinical parameters, such as the albumin excretion
rate and blood pressure values, and the [(Ca2)] response to FUF
challenge, we plotted together these results and found an inter-
esting relationship in NIDDM H+M+ between microalbumin-
uria and [(Ca2)1] (P = 0.028, r = 0.721). In NIDDM H—M—,
there was also a direct relationship between [(Ca2)1] release at 22
m glucose concentration in the presence of insulin and diastolic
blood pressure (P = 0.027, r = 0.811).
Mn2 quench experiments
By monitoring the activity of the FGF-stimulated [(Ca2)] with
the above described method, we confirmed the results obtained in
previous experiments. In cells preincubated at 5.5 m glucose
concentration, stimulation with FGF resulted in a decreased fluores-
cence intensity to 72 3% of the initial intensity. In cells preincu-
bated with glucose 22 m, the Mn2 flux was significantly increased
in all groups (to 54 5% of the initial fluorescence; Fig. 5).
Discussion
The novel findings of the present study are that: (1) cultured
skin fibroblasts from a group of hypertensive NIDDM patients
with or without abnormal albumin excretion rate show a higher
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Fig. 1. Mean effect of fibroblast growth factor
(FGF) challenge on [(Ca2)j (nmol/liter) in
cultured skin fibroblasts from seven control
________
subjects (Controls), as recorded by the
luminescence spectrometer. See Table 3 for
values. A. 5.5 mi D-glucose concentration in
the absence of insulin. B. 5.5 mM D-glucose
I I I -I concentration in the presence of insulin.
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[(Ca2)1] response to FGF challenge during chronic exposure to
high glucose or insulin concentrations than those from normoten-
sive normoalbuminuric NIDDM patients and control subjects. (2)
When both hormonal and metabolic stimuli are combined, all
NIDDM patients have altered fibroblast [(Ca2)] handling, but in
the cohort characterized by arterial hypertension, microalbumin-
uria and glomerular hyperfiltration, [(Ca2)] handling is higher
not only in comparison with controls but also with normotensive
normoalbuminuric NIDDM patients. (3) Hypertensive non-dia-
betic patients show disturbances of intracellular calcium ho-
meostasis resembling those of hypertensive NIDDM patients.
These results are in keeping with the tenet that defective
calcium handling by cells is a fundamental disorder of NIDDM
state. However, they provide evidence that an altered calcium
content is an intrinsic feature of the cellular metabolism of
NIDDM patients with hypertension and altered albumin excre-
tion rate. In fact, should be noted that these disturbances in
calcium homeostasis are found in fibroblasts distant from the
environmental diabetic milieu of NIDDM patients after several
passages of culture in vitro. The observation of comparable
disturbances in [(Ca2)j handling in non-diabetic and NIDDM
hypertensive patients suggests that pathogenetic mechanisms
linked to arterial hypertension contribute to the determination of
disorders of cell calcium metabolism at least partially irrespective
of diabetic disease. This takes into account the difference in
[(Ca2)1] regulation by high glucose or insulin that was not
correlated to the patterns of metabolic control, duration of
diabetes, age and body mass index, which were similar in all
NIDDM patients in this study irrespective of blood pressure and
albumin excretion rate patterns.
It can be postulated that the changes in calcium homeostasis
are secondary to the metabolic derangements to which cultured
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Table 3. (Ca2) (nmol/liter) response to fibroblast growth factor challenge at 5.5 and 22 m glucose concentrations with and without chronic
insulin stimulation in cultured skin fibroblasts from seven Controls, five hypertensive, non-diabetic subjects (HYPER), seven normotensive
normoalbuminurie NIDDM patients (NIDDM H—M—), seven hypertensive normoalbuminuric NIDDM patients (NIDDM H+M—) and nine
hypertensive mieroalbuminuric NIDDM patients (NIDDM H+M+)
Without chronic insulin stimulation With chronic insulin stimulation
5.5 mM glucose 22 m glucose 5.5 m glucose 22 m glucose
Controls 143.7 6.9 170.6 11.3 231.5 10.4" 249.6 10.5"
HYPER 148.3 5.1 230.8 7.5 289.4 7.9"" 464.6 g3ahcd
NIDDM H—M— 151.3 11.0 188.7 9.6" 253.4 101h 391.4 121"""
NIDDM H+M— 160.6 7.3 236.1 8.4'"' 303.8 9.6" 481.2 99C
NIDDM H+M+ 165.6 5.6 240.4 11.5""" 310.9 10.6"' 472.8 22.9""'
Data are expressed as mean SE.
"P < 0.05 vs. 5.5 m glucose concentration; "P < 0.05 vs. without insulin; C < 0.05 vs. Controls; dp < 0.05 vs. NIDDM H—M—
skin fibroblasts have been exposed in vivo: if this environmental findings are in keeping with the reports of Roy et al [24], who
factor is responsible for the pathogenesis, it determines a perma- examined whether or not diabetes induces changes in gene
nent defect, which is immortalized in cell function in vitro. These expression that were able to outlast the presence of the metabolic
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Table 4. (Ca2) response (nmol/liter) to fibroblast growth factor
challenge in cultured skin fibroblasts from Controls, hypertensive non-
diabetic patients (HYPER), normotensive normoalbuminuric NIDDM
patients (NIDDM H—M—), hypertensive normoalbuminuric NIDDM
patients (NIDDM H+M—) and hypertensive microalbuminuric
NIDDM patients (NIDDM H+M+)
G I 1GI
Controls
HYPER
NIDDM H—M—
NIDDM H+M—
NIDDM H+M+
23.2 2.6
80.6 37ab
41.0 1.5
73•9 33ab
74.8 11.4""
87.7 10.8
138.9 6.7a
100.7 6.9
142.1 7.6"
145.3 128ab
107.5 13.5
310.3 8.7'
241.1 14.5"
322.6 lola
319.9 17.3"
Data are expressed as mean delta SE ( G, values at 22 mM minus
values at 5.5 mrvi glucose concentration the absence of insulin; z I, values
at 5.5 m in the presence of insulin minus values at 5.5 M in the absence
of insulin; and GI, values at 22 m in the presence of insulin minus
values at 5.5 mi in the absence of insulin).
a P < 0.05 vs. Controls
"p < 0.05 vs. NIDDM H—M-
abnormalities in vivo. They showed that in streptozotocin-induced
diabetic rats, elevation of fibronectin mRNA levels persisted for
weeks after the restoration of near normoglycemia. These in vitro
studies suggest that hyperglycemia may be responsible for the
development of complications in diabetes throughout induction of
self-perpetuating changes in gene expression.
On the other hand, this hypothesis can align with the view that
a primary abnormality in hormonal regulation of [(Ca2)] is a
further basic cellular defect of that subgroup of NIDDM patients
who have hypertension and have the potential to develop diabetic
complications. This view is supported by the current study,
showing that [(Ca2)I surges following an abrupt challenge with
FGF, and chronic combined exposure to high glucose and insulin
concentrations are more markedly increased in NIDDM patients
with hypertension and/or microalbuminuria. Whether or not the
changes in calcium metabolism in fibroblasts from microalbumin-
uric, hypertensive NIDDM patients are primarily genetic or
acquired defects is not elucidated by our study.
Our results also contribute to further insight into the sequence
of events leading to the development of organ complications in
NIDDM. The disturbances in [(Ca2)1] persist in cells from
NIDDM patients who have complications after several passages
of culture in vitro. We did not observe differences in vivo in the
patterns of lipid and carbohydrate metabolism in the two sub-
groups of NIDDM patients with and without renal and cardiovas-
cular abnormalities during the last two years of follow-up. Nev-
ertheless, one cannot rule out the possibility that the cohort of
NIDDM patients with microalbuminuria had sustained more
severe derangement of metabolic control in the previous years in
comparison with those patients who did not have microangio-
pathic complications. Alternatively, it can be suggested that a
disorder linked to hypertension and/or to predisposition to hyper-
tension, rather than to hyperglycemia itself, determines an altered
capacity of the [(Ca2)] response to FGF, insulin and glucose
toxicity. This latter view is supported by the observation that skin
fibroblasts from spontaneously hypertensive rats show an en-
hanced mitogenic response to insulin and epidermal growth factor
[25].
Eventually a primary genetic defect could lag behind the
abnormalities of calcium regulation by cultured fibroblasts in vitro.
Levy, Sowers and Zemet [261 showed that the malfunction of
plasma membrane calcium ATP-ase activity, an enzyme implied in
[(Ca2)1I metabolism, is not restricted to one tissue and appears
to be a generalized pathology in a model of the non-insulin
dependent diabetic rat. Furthermore, two recent reviews have also
postulated that cellular disturbances in [(Ca2),J handling could
be genetically determined in diabetes [1, 271. These observations
from experimental diabetes in animals are also in agreement with
the observation that normotensive offsprings of patients with
essential hypertension have both impaired insulin sensitivity and
disturbed calcium metabolism [28].
We show that high glucose and insulin concentrations increase
the FGF-induced [(Ca2),J response of fibroblasts both from
controls and NIDDM patients, but that this effect is exaggerated
in hypertensive microalbuminuric NIDDM. FGF is a powerful
stimulus for cellular growth and proliferation. Growth factors and
insulin mediate mitogenic events without activating the polyphos-
phoinositide breakdown [29, 30], but through signaling pathways
initiated by tyrosine phosphorylation [18], which in turn lead to
changes in [(Ca2),] [1]. We have previously shown that NIDDM
patients with hypertension and microalbuminuria are character-
ized by renal and cardiac hypertrophy that are not only explained
by abnormalities in blood pressure levels [111. The observed
disturbance in hormonal and metabolic regulation of FGF in-
duced [(Ca2)I in vitro, outlasting the presence of the metabolic
abnormalities, could be one of the pathogenetic mechanisms
leading to the development of renal and cardiac disorders in this
cohort of NIDDM patients.
In human endothelial cells in vitro, the overexpression of
basement membrane components induced by high glucose levels
is mediated at the level of transcription without evidence of
translational regulation [31]. This finding suggests that some
cellular changes induced by diabetes may have a prolonged half
life. However, it has to be highlighted that HbAlc patterns and
the type of antidiabetic treatment in vivo were similar in NIDDM
H-M—, NIDDM H+M- and NIDDM H+M+. Therefore, it
appears unlikely that the so-called "glucose-memory effect" ac-
counts for the results of the present study. Moreover, no differ-
ence was found between NIDDM patients on diet, glibenclamide
or insulin treatment in vivo, suggesting that it is unlikely that
suiphonilurea action was the determinant of the intrinsic defects
of [(Ca2),] homeostasis in vitro.
The reported changes in [(Ca2),] are not due to hyperosmo-
larity since they were not reproduced by the addition of mannitol
to the cell culture medium (data not shown). Furthermore,
extracellular free calcium concentration of the culture medium
and derangements in the transport process of free calcium from
extracellular medium to cytosol do not appear to be of signifi-
cance, as altered [(Ca2)I handling was also observed in fibro-
blasts cultured in calcium free media. Therefore the basic defect
underlying the increased [(Ca2),] surge after an abrupt FGF
stimulation and chronic exposure to glucose and insulin in cul-
tured fibroblasts of NIDDM patients could involve intracellular,
rather than extracellular mechanisms of free calcium homeostasis.
These findings are also in keeping with accumulating data from
animals and humans with diabetes that reveal increased [(Ca2),]
in most tissues. Levi et al [1] have recently summarized reports in
literature suggesting that the nature of this alteration is often
tissue specific, and therefore caution must be used in extrapolat-
ing the present observations in fibroblasts to other cell types.
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Fig. 4. [(Ca2)j response (nmollliter) to a fibro blast growth factor (FGF) challenge, as recorded by the luminescence spectrometer in cultured skin fibro blasts
from one normal subject (A), one normotensive normoalbuminuric NIDDM patient (B) and one hypertensive microalbuminuric NIDDM patient (C) at 22
mM glucose concentration in Ca2 k-free HEPES-buffered solution, along with chronic insulin stimulation.
0
CO
C,)
LL
100
80
60
40
20
0
Time, minutes
Fig. 5. Fibroblast growth factor (FGF)-induced Mn2 entty into human
fibroblasts at 5.5 mM (0) and 22 mat (S) D-glucose concentration. On the
Y axis is the percentage of the initial fluorescence intensity.
In conclusion, a subgroup of NIDDM patients with a possibly
genetically determined predisposition to develop complications,
show an altered intracellular calcium response to FGF after
prolonged exposure to metabolic or hormonal stimuli. Clearly,
further studies involving characterization of all components of the
Ca2 signal transduction cascade are warranted to elucidate the
role of intracellular calcium homeostasis in the pathogenesis of
diabetic complications.
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